Evaluation of Liver Function and Lipid profiles in Iraqi patients with Rheumatoid Arthritis

Evaluation of Liver Function and Lipid profiles in Iraqi patients with Rheumatoid Arthritis
复制标题

伊拉克类风湿性关节炎患者的肝功能和血脂谱评估

DOI:
10.1088/1742-6596/1853/1/012040
复制
发表时间:
2021
期刊:
Journal of Physics: Conference Series
影响因子:
--
通讯作者:
F. S. Al
F. S. Al
中科院分区:
--
文献类型:
--
作者:
R. Khadim;F. S. Al

文献摘要

参考文献

被引文献

相似文献

类风湿性关节炎 (RA) 是一种慢性自身免疫性炎症性疾病,具有影响关节的破坏性模式。它影响关节的滑膜衬里组织。女性患类风湿性关节炎的风险高于男性。类风湿性关节炎的主要治疗方法是缓解病情的抗风湿药(DMARD),例如甲氨蝶呤(MTX)和依那西普。在这项研究中,评估了类风湿性关节炎患者的ESR、CRP、肝功能酶、肾功能测试和血脂谱。该研究包括 120 名女性类风湿性关节炎患者和 60 名健康个体作为对照组,年龄范围在(20-60)岁之间。获得的结果表明,与对照值相比,患者的 ESR、CRP 活性显着增加(p <0.01)。结果还表明,与对照值相比,类风湿性关节炎的肝酶活性、肾功能和脂质谱参数显着增加。总之,甲氨蝶呤等 DMARD 治疗似乎可能是导致肾功能损害等许多并发症的原因。在此基础上,当甲氨蝶呤对肝酶活性、肾功能、血脂水平产生影响时,我们可以建议患者降低甲氨蝶呤的每周剂量,和/或当甲氨蝶呤不再有益时改变治疗。
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease with a destructive pattern that affects the joints. It affects the synovial lining tissue of the joints. Females develop rheumatoid arthritis at a higher risk than males. The main treatment for rheumatoid arthritis is disease-modifying anti-rheumatic agents (DMARD) such as methotrexate (MTX) and Etanercept. In this study, ESR, CRP, liver function enzymes, renal function tests and lipid profile were evaluated for rheumatoid arthritis patients. The study includes 120 female patients with rheumatoid arthritis and 60 healthy individuals as a control group with an age range between (20-60) years. The obtained results indicated a significant increase in ESR, CRP activity (p <0.01) in patients compared to the control values. The results also indicated a substantial increase in liver enzymes activity, renal function and lipid profile parameters in rheumatoid arthritis compared to the control values. In conclusion, it appears that DMARD treatment such as methotrexate may be the cause of many complications such as renal impairment. On this basis, we can suggest lowering the weekly dose of methotrexate to patients when effects on liver enzymes activity, renal function, lipid profiles and/or changing treatment when MTX is no longer beneficial.
DOI: 10.1073/pnas.78.11.6858
发表时间: 1981-01-01
期刊: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES
影响因子: --
作者:
AMES, BN;CATHCART, R;HOCHSTEIN, P
通讯作者: HOCHSTEIN, P
DOI: 10.1093/gerona/gls102
发表时间: 2012-06-01
影响因子: 5.1
作者:
Higashi, Yusuke;Sukhanov, Sergiy;Delafontaine, Patrice
通讯作者: Delafontaine, Patrice
DOI: 10.1172/jci40124
发表时间: 2010-06-01
影响因子: 15.9
作者:
Kono, Hajime;Chen, Chun-Jen;Rock, Kenneth L.
通讯作者: Rock, Kenneth L.
DOI: 10.1016/s1089-3261(02)00052-1
发表时间: 2002-11-01
影响因子: 5.1
作者:
Walker, Nancy J;Zurier, Robert B
通讯作者: Zurier, Robert B